For citations:
Mingalimov M.A., Baryakh E.A., Misyurin A.V., Kesaeva L.A., Mkrtchyan A.S., Misyurina E.N., Tolstykh T.N., Orlova M.S., Akhmadeeva A.A., Chudnova T.S., Ivanova D.D., Kochneva O.L., Zotina E.N., Makeshova A.B., Andreev S.S., Yatskov K.V., Samsonova I.V., Lysenko M.A. Personalized genotype-directed antitumor therapy for newly diagnosed diffuse large B-cell lymphoma: efficacy and toxicity of the R-CHOP-X protocol in a single-center, non-randomized, prospective clinical trial (first results). Oncohematology. 2024;19(4):84-92. (In Russ.) https://doi.org/10.17650/1818-8346-2024-19-4-84-92